Insider filing · ARWR
Victoria Vakiener
Director
profile →
Arrowhead Pharmaceuticals, Inc.
ARWR · Healthcare · 34 filings in 24 months
ticker →
Victoria Vakiener sold $679K of Arrowhead Pharmaceuticals (ARWR)
Executed Dec 19 2025, disclosed Dec 23 2025, 4 days later.
Value, as filed
$679K
10,040 sh across 3 lots
Executed
Dec 19 2025
the trade date, as filed
Disclosed
Dec 23 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
VVVictoria Vakiener (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Arrowhead Pharmaceuticals, Inc. (ARWR). The largest single filing was $679K of ARWR (10,040 sh across 3 lots, as filed), executed Dec 19 2025.
The name
ARWRHealthcare · Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Victoria Vakiener in ARWR
ARWRSALE
Arrowhead Pharmaceuticals, Inc.
$197K8,994 sh × $21.91
Exec Dec 16 2024
Filed Dec 18 2024 · 5:30 PM ET